Hims & Hers Health, Inc. $HIMS Position Lessened by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. decreased its position in Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 95.9% in the third quarter, Holdings Channel reports. The institutional investor owned 7,235 shares of the company’s stock after selling 167,815 shares during the period. Landscape Capital Management L.L.C.’s holdings in Hims & Hers Health were worth $216,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Versant Capital Management Inc grew its position in shares of Hims & Hers Health by 801.2% during the 2nd quarter. Versant Capital Management Inc now owns 748 shares of the company’s stock valued at $26,000 after acquiring an additional 665 shares during the period. MassMutual Private Wealth & Trust FSB increased its stake in shares of Hims & Hers Health by 70.0% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 775 shares of the company’s stock valued at $27,000 after purchasing an additional 319 shares in the last quarter. GK Wealth Management LLC acquired a new position in Hims & Hers Health in the 3rd quarter worth about $37,000. Compass Financial Management LLC acquired a new position in Hims & Hers Health in the 2nd quarter worth about $50,000. Finally, Integrated Wealth Concepts LLC acquired a new position in Hims & Hers Health in the 2nd quarter worth about $147,000. Institutional investors and hedge funds own 63.52% of the company’s stock.

Hims & Hers Health Trading Down 9.1%

Shares of HIMS stock opened at $14.57 on Friday. Hims & Hers Health, Inc. has a fifty-two week low of $13.74 and a fifty-two week high of $40.99. The company has a debt-to-equity ratio of 3.85, a quick ratio of 0.84 and a current ratio of 0.92. The stock’s fifty day moving average is $26.51 and its two-hundred day moving average is $26.43. The firm has a market capitalization of $3.42 billion, a P/E ratio of -17.55 and a beta of 2.53.

Hims & Hers Health (NYSE:HIMS – Get Free Report) last released its quarterly earnings data on Monday, November 9th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.03). Hims & Hers Health had a negative net margin of 6.65% and a negative return on equity of 9.62%. The business had revenue of $890.37 million during the quarter, compared to analyst estimates of $893.13 million. During the same quarter in the previous year, the company posted $0.06 EPS. The firm’s revenue was up 48.6% on a year-over-year basis. Research analysts expect that Hims & Hers Health, Inc. will post -0.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Jefferies Financial Group decreased their target price on Hims & Hers Health from $31.00 to $24.00 and set a “hold” rating on the stock in a research report on Tuesday, November 10th. Truist Financial boosted their price target on shares of Hims & Hers Health from $27.00 to $32.00 and gave the stock a “hold” rating in a report on Monday, August 24th. Weiss Ratings restated a “sell (d)” rating on shares of Hims & Hers Health in a research report on Wednesday, November 4th. JPMorgan Chase & Co. started coverage on shares of Hims & Hers Health in a research report on Friday, September 11th. They set a “neutral” rating and a $32.00 price objective for the company. Finally, TD Cowen increased their price objective on shares of Hims & Hers Health from $25.00 to $30.00 and gave the company a “hold” rating in a report on Tuesday, August 11th. Three equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $30.80.

Get Our Latest Research Report on Hims & Hers Health

Insider Activity at Hims & Hers Health

In related news, COO Michael Chi sold 14,027 shares of the stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $28.39, for a total value of $398,226.53. Following the transaction, the chief operating officer directly owned 456,660 shares of the company’s stock, valued at $12,964,577.40. This trade represents a 2.98% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Oluyemi Okupe sold 3,518 shares of the business’s stock in a transaction on Tuesday, November 17th. The shares were sold at an average price of $18.53, for a total transaction of $65,188.54. Following the completion of the sale, the chief financial officer directly owned 266,188 shares of the company’s stock, valued at approximately $4,932,463.64. This trade represents a 1.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 105,041 shares of company stock worth $2,764,840 over the last 90 days. 11.76% of the stock is owned by corporate insiders.

Hims & Hers Health Profile

(Free Report)

Hims & Hers Health, Inc. operates a consumer-focused telehealth platform that connects patients with licensed healthcare providers and offers access to treatments and wellness products. Its services include online consultations, prescription care and over-the-counter products. The company serves a range of health needs, including hair loss, sexual health, skin care, mental health and weight management. Its platform also offers primary care and other services, with offerings varying by location and individual eligibility.

Further Reading

Want to see what other hedge funds are holding HIMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hims & Hers Health, Inc. (NYSE:HIMS – Free Report).

Institutional Ownership by Quarter for Hims & Hers Health (NYSE:HIMS)

Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.